Hypothermic Oxygenated machine PErfusion for high‐risk liver grafts for transplantation: A systematic review and meta‐analysis
Artificial Organs · 2024-10 · 48 (10) · 1085-1099
DOI: 10.1111/aor.14814 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Artificial Organs, online erschienen am 22.06.2024. Verfasst von Charles W G Risbey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Liver Transplantation, Perfusion, Organ Preservation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypothermic Oxygenated machine PErfusion (HOPE) can reduce ischemic reperfusion injury and improve outcomes for liver transplant recipients. However, the effect of HOPE on high‐risk extended criteria donor (ECD) and donation after circulatory death determination (DCDD) grafts is incomplete, despite the expectation that this cohort benefit maximally from HOPE. Accordingly, this paper aims to characterize the effect of HOPE on ECD and DCDD grafts.
Methods
This study includes all papers comparing HOPE to static cold storage for high‐risk ECD and DCDD grafts. Systematic searches of Medline, Embase, and Scopus were completed using the terms “HOPE” OR “hypothermic oxygenated machine perfusion” AND “liver transplantation”. Data were extracted and analyzed using IBM SPSS to perform the meta‐analysis.
Results
A total of 2286 records were identified, with 10 meeting the inclusion criteria. Overall, the quality of evidence is heterogenous with many papers relying on retrospective controls. However, pooled analysis demonstrates HOPE to significantly reduce the rate of early allograft dysfunction, 12‐month graft failure, re‐transplantation, total biliary complications, and non‐anastomotic strictures for high‐risk grafts.
Conclusions
There is good evidence that HOPE improves outcomes following liver transplantation across a number of biochemical and clinical endpoints for high‐risk grafts. Of note, the reduction in biliary complications and re‐transplantation is particularly significant given the morbidity associated with these endpoints. However, further, high‐quality prospective trials with contemporary controls and clinically relevant primary endpoints are needed to better define the impact of HOPE for this cohort of grafts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Transplant Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Centre for Organ Assessment, Repair, & Optimization (COARO), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Royal Prince Alfred Hospital Transplant Institute (RPATI), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Australian National Liver Transplantation Unit (ANLTU), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Charles W G Risbey, Anita Niu, Carlo Pulitano
Zitieren
APA
Risbey, C. W. G., Thomas, C., Niu, A., Liu, K., Crawford, M., & Pulitano, C. (2024). Hypothermic Oxygenated machine PErfusion for high‐risk liver grafts for transplantation: A systematic review and meta‐analysis. Artificial Organs, 48(10), 1085-1099. https://doi.org/10.1111/aor.14814
Vancouver
Risbey CWG, Thomas C, Niu A, Liu K, Crawford M, Pulitano C. Hypothermic Oxygenated machine PErfusion for high‐risk liver grafts for transplantation: A systematic review and meta‐analysis. Artificial Organs. 2024;48(10):1085-1099. doi:10.1111/aor.14814
BibTeX
@article{Risbey2024,
author = {Risbey, Charles W G and Thomas, Charles and Niu, Anita and Liu, Ken and Crawford, Michael and Pulitano, Carlo},
title = {Hypothermic Oxygenated machine PErfusion for high‐risk liver grafts for transplantation: A systematic review and meta‐analysis},
journal = {Artificial Organs},
year = {2024},
volume = {48},
number = {10},
pages = {1085--1099},
doi = {10.1111/aor.14814}
}
EUVIMED